PTGS2 and Alzheimer disease: Furthermore, the compounds demonstrated the inhibition of cyclooxygenase-2 (COX-2) and lipoxygenase-5 (LOX-5) activities, which are associated with the progression of AD through the mediation of inflammation and oxidative stress.